Vascular Dynamics taps ex-Ellipse Tech CEO Roschak as chief exec | Personnel Moves December 15, 2017

Vascular Dynamics said early this month it tapped former NuVasive Inc. (NSDQ:NUVA) exec and Ellipse Technologies CEO Ed Roschak as its new president and chief executive. Prior to joining Mountain View, Calif.-based Vascular Dynamics, Roschak served as prez and CEO of Ellipse Technologies, which he saw through a $410 million acquisition by NuVasive. He then took up a position as CEO of NuVasive’s specialized orthopedics business. “We are fortunate that Ed has decided to join the VDI Team as CEO.  He has extensive experience in managing the IDE/PMA process with the FDA, raising capital to finance complex clinical studies, managing a rapid revenue ramp for novel, clinically superior devices and successfully guiding companies through the exit process. These skills make Ed an excellent fit for Vascular Dynamics as we begin the CALM 2 IDE-approved, pivotal clinical study in the U.S., maximize the value of the Expedited Access Pathway for the VDI Mobius system granted to us by the FDA, and prepare for worldwide commercialization,” VDI chair Michael Henson said in a prepared statement. Before his seven years at Ellipse, Roschak held positions at pulmonology startup Broncus Technology, which spun out Asthmatx which was later acquired by Boston Scientific (NYSE:BSX). “The use of VDI’s MobiusHD device in the first 68 patients with resistant hypertension has produced outstanding results, exceeding anything published to date by alternative devices.  I ...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Aptus EndoSystems Inc. Asante Solutions Boston Scientific Cutera Inc. Ellipse Technologies Inc. Encision Inc. Genoptix Inc. Halyard Health Hologic johnsonandjohnson Novartis Nuvasive Presbia regentys t Source Type: news